Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Items 101–200 of 698
Pre-transplant weight loss and clinical outcomes after lung transplantation
Clausen, E. S., Frankel, C., Palmer, S. M., Snyder, L. D., & Smith, P. J. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.07.015 · Cited by 45
Self-citationLoor, G., Brown, R. Z., Kelly, R. F., Rudser, K. D., Shumway, S. J., Cich, I., Holley, C. T., Quinlan, C., & Hertz, M. I. (2017) · Clinical Transplantation · doi:10.1111/ctr.12889 · Cited by 46
Bottiger, B., Nicoara, A., Snyder, L. D., Wischmeyer, P. E., Schroder, J. N., Patel, C. B., Daneshmand, M. A., Sladen, R. N., & Ghadimi, K. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.08.002 · Cited by 45
Eberlein, M. H., Diehl, E., Bölükbas, S., Merlo, C. A., & Reed, R. M. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.06.011 · Cited by 44
Prolonged Mechanical Ventilation After Lung Transplantation—A Single-Center Study
Hadem, J., Gottlieb, J., Seifert, D., Fegbeutel, C., Sommer, W., Greer, M., Wiesner, O., Kielstein, J. T., Schneider, A., Ius, F., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13632 · Cited by 43
“PAH has been linked to PGD, which is an independent risk factor for short- and long-term mortality (26).”
BackgroundDepressive symptoms and early mortality following lung transplantation: A pilot study
Smith, P. J., Blumenthal, J. A., Snyder, L. D., Mathew, J. P., Durheim, M. T., Hoffman, B. M., Rivelli, S. K., & Palmer, S. M. (2016) · Clinical Transplantation · doi:10.1111/ctr.12874 · Cited by 43
Self-citationHistorical perspectives of lung transplantation: connecting the dots
Panchabhai, T. S., Chaddha, U., McCurry, K. R., Bremner, R. M., & Mehta, A. C. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.06 · Cited by 46
“Its reported incidence is highly variable (generally 10% to 25%) (62,63).”
BackgroundAnderson, M. R., Udupa, J. K., Edwin, E. A., Diamond, J. M., Singer, J. P., Kukreja, J., Hays, S. R., Greenland, J. R., Ferrante, A. W., Lippel, M., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.013 · Cited by 45
“In order to demonstrate the durability of the effect estimates, (1) we performed sensitivity analyses with models adjusted for individual covariates, and (2) we have presented our results in a “model-building” format in which we sequentially adjusted for groups of covariates.”
BackgroundMethodInfluentialSelf-citationInhaled nitric oxide in cardiac surgery: Evidence or tradition?
Benedetto, M., Romano, R., Baca, G. L., Sarridou, D. G., Fischer, A., Simon, A. R., & Marczin, N. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.06.002 · Cited by 46
The role of cardiopulmonary bypass in lung transplantation
Mohite, P. N., Sabashnikov, A., Patil, N. P., García‐Sáez, D., Zych, B., Zeriouh, M., Romano, R., Soresi, S., Reed, A. K., Carby, M. R., et al. (2015) · Clinical Transplantation · doi:10.1111/ctr.12674 · Cited by 42
“Utilization of CPB in LTx has historically been linked to an increased risk of PGD (7, 8).”
BackgroundInfluentialSher, Y., Mooney, J., Dhillon, G., Lee, R., & Maldonado, J. R. (2017) · Clinical Transplantation · doi:10.1111/ctr.12966 · Cited by 41
Smith, I., Pearse, B. L., Faulke, D. J., Naidoo, R., Nicotra, L., Hopkins, P. M.-A., & Ryan, E. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.06.027 · Cited by 41
Extracorporeal membrane oxygenation following lung transplantation: indications and survival
Mulvihill, M. S., Yerokun, B. A., Davis, R. P., Ranney, D. N., Daneshmand, M. A., & Hartwig, M. G. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.06.014 · Cited by 45
Local complement activation is associated with primary graft dysfunction after lung transplantation
Kulkarni, H. S., Ramphal, K., Ma, L., Brown, M., Oyster, M. L., Speckhart, K., Takahashi, T., Byers, D. E., Porteous, M. K., Kalman, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138358 · Cited by 41
“This has been previously reported in multicenter studies, wherein the range of severe PGD ranged from 2%–27% (47).”
BackgroundSelf-citationCirculating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation
Hashimoto, K., Besla, R., Zamel, R., Juvet, S., Kim, H., Azad, S., Waddell, T. K., Cypel, M., Liu, M., & Keshavjee, S. H. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2115oc · Cited by 43
Genetic Variation in the Prostaglandin E2 Pathway Is Associated with Primary Graft Dysfunction
Diamond, J. M., Akimova, T., Kazi, A. S., Shah, R., Cantu, E., Feng, R., Levine, M. H., Kawut, S. M., Meyer, N. J., Lee, J. C., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1283oc · Cited by 40
Self-citationPottecher, J., Roche, A.-C., Dégot, T., Helms, O., Hentz, J.-G., Schmitt, J.-P., Falcoz, P., Santelmo, N., Levy, F., Collange, O., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001434 · Cited by 40
“Excluding patients with either SLT (n = 5) or ECMO use (n = 0) did not alter the predictive value of H6 PVPi for grade 3 PGD.”
InfluentialAnderson, B. J., Chesley, C. F., Theodore, M., Christie, C., Tino, R., Wysoczanski, A., Ramphal, K., Oyster, M. L., Kalman, L., Porteous, M. K., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.01.1295 · Cited by 42
“Delirium and PGD may result from shared mechanisms, supported by our finding that ischemic time, an established PGD risk factor (52), is also a risk factor for delirium.”
BackgroundSelf-citationAkimova, T., Zhang, T., Christensen, L. M., Wang, Z., Han, R., Negorev, D., Samanta, A., Sasson, I. E., Gaddapara, T., Jiao, J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4306oc · Cited by 41
Self-citationWare, L. B., Lee, J. W., Wickersham, N. E., Nguyen, J., Matthay, M. A., & Calfee, C. S. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12853 · Cited by 39
“For example, in a prospective cohort study of 1255 lung transplant recipients by the Lung Transplant Outcomes Group, donor smoking was an independent risk factor for primary graft dysfunction after lung transplantation (18).”
BackgroundSelf-citationMa, X., Yan, W., & He, N. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12666 · Cited by 42
“lung i/r injury (liri) usually occurs in various clinical situations, including cardiac arrest, trauma, pulmonary thrombosis, lung transplantation and cardiopulmonary bypass surgery (2,3).”
BackgroundRisk factors predictive of one-year mortality after lung transplantation
Sabashnikov, A., Weymann, A., Mohite, P. N., Zych, B., Patil, N. P., Garcia Saez, D., Popov, A.-F., Zeriouh, M., Wahlers, T., Wittwer, T., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu383 · Cited by 39
Lung Retransplantation for Chronic Rejection: A Single-Center Experience
Roy, S. B., Panchanathan, R. S., Walia, R., Varsch, K. E., Kang, P. T., Huang, J. L., Hashimi, A. S., Mohanakumar, T., Bremner, R. M., & Smith, M. A. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.07.025 · Cited by 41
Primary graft dysfunction after lung transplantation
Hunt, M. L., & Cantu, E. (2023) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001065 · Cited by 42
“Copyright © 2023 Wolters Kluwe diagnoses consistently shown to increase the risk of PGD include pulmonary arterial hypertension, idiopathic pulmonary fibrosis and sarcoidosis [42,44].”
BackgroundResultSelf-citationAvriel, A., Klement, A. H., Johnson, S. R., de Perrot, M. E., & Granton, J. T. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14352 · Cited by 40
Shah, R., Emtiazjoo, A. M., Diamond, J. M., Smith, P., Roe, D., Wille, K. M., Orens, J. B., Ware, L. B., Weinacker, A. B., Lama, V. N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2121le · Cited by 38
Self-citationSamano, M. N., Fernandes, L. M., Baranauskas, J. C. B., Correia, A. T., Afonso, J. E., Teixeira, R. H. D. O. B., Caramori, M. L., Pêgo‐Fernandes, P. M., & Jatene, F. B. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.07.134 · Cited by 38
Lin, F., Feng, J., Tiantian, W., He, Y., & Linghui, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00389 · Cited by 39
“Inflammatory response has significant role in tissue damage after organ ischemiareperfusion (I/R) (Gelderblom et al., 2012; Diamond et al., 2013; Phelan et al., 2015).”
BackgroundAdvances in Human Lung Transplantation
Swaminathan, A. C., Todd, J. L., & Palmer, S. M. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-080119-103200 · Cited by 38
Self-citationLung Transplantation for Pulmonary Arterial Hypertension
Kolaitis, N. A. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.047 · Cited by 40
Verleden, S. E., Martens, A., Ordies, S., Neyrinck, A., Raemdonck, D. E. V., Verleden, G. M., Vanaudenaerde, B. M., & Vos, R. (2018) · Clinical Transplantation · doi:10.1111/ctr.13219 · Cited by 36
İskender, İ., Cypel, M., Martinu, T., Chen, M., Sakamoto, J., Kim, H., Yu, K., Lin, H., Guan, Z., Hashimoto, K., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002140 · Cited by 36
“Specific donor- and recipientrelated factors also contribute to PGD in the clinical setting.(5,6) Traditionally, in lung transplantation, donor lungs undergo a period of ischemia, which starts from flushing of the graft until its reperfusion.”
BackgroundEffects of Smoking on Solid Organ Transplantation Outcomes
ANIS, K. H., Weinrauch, L. A., & D’Elia, J. A. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.11.005 · Cited by 37
Sladden, T. M., Yerkovich, S. T., Grant, M., Zhang, F., Liu, X., Trotter, M., Hopkins, P. M.-A., Linhardt, R. J., & Chambers, D. C. (2018) · Transplantation · doi:10.1097/tp.0000000000002539 · Cited by 36
Advances in lung ischemia/reperfusion injury: unraveling the role of innate immunity
Li, Q., & Nie, H. (2024) · Inflammation Research · doi:10.1007/s00011-023-01844-7 · Cited by 38
“This condition occurs in various scenarios, including lung transplantation, pulmonary embolism, cardiothoracic surgery with cardiopulmonary bypass, and cardiac arrest [1].”
Cantu, E., Shah, R., Lin, W. C., Daye, Z. J., Diamond, J. M., Suzuki, Y., Ellis, J. H., Borders, C. F., Andah, G., Beduhn, B., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.09.077 · Cited by 35
Self-citationEnvironmental Risk Factors for Acute Respiratory Distress Syndrome
Moazed, F., & Calfee, C. S. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.08.003 · Cited by 37
Evaluation and Management of the Potential Lung Donor
Courtwright, A., & Cantu, E. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.07.007 · Cited by 35
Self-citationPrimary graft dysfunction: pathophysiology to guide new preventive therapies
Shaver, C. M., & Ware, L. B. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1280398 · Cited by 40
“For example, PGD grade 2 (PaO2/FiO2 200–300) or grade 3 (PaO2/ FiO2 < 200) is associated with increased short- and long-term mortality [3,4].”
BackgroundSelf-citationTonelli, A. R., & Lane, C. R. (2015) · International Journal of COPD · doi:10.2147/copd.s78677 · Cited by 39
Zhang, Z. L., van Suylen, V., van Zanden, J. E., Wauwer, C. V. D., Verschuuren, E. A. M., van der Bij, W., & Erasmus, M. E. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy373 · Cited by 34
Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
Bartolome, S., Hoeper, M. M., & Klepetko, W. (2017) · European Respiratory Review · doi:10.1183/16000617.0089-2017 · Cited by 41
Heavy Alcohol Use in Lung Donors Increases the Risk for Primary Graft Dysfunction
Lowery, E. M., Kuhlmann, E. A., Mahoney, E., Dilling, D. F., Kliethermes, S., & Kovacs, E. J. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12553 · Cited by 33
Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction
Monticelli, L. A., Diamond, J. M., Saenz, S. A., Wojno, E. D. T., Porteous, M. K., Cantu, E., Artis, D., & Christie, J. D. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201906-1113oc · Cited by 34
Self-citationDiamond, J. M., Porteous, M. K., Roberts, L. J., Wickersham, N. E., Rushefski, M., Kawut, S. M., Shah, R., Cantu, E., Lederer, D. J., Chatterjee, S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.12.012 · Cited by 34
Self-citationCigarette Smoke Exposure Worsens Endotoxin-Induced Lung Injury and Pulmonary Edema in Mice
Gotts, J. E., Abbott, J. A., Fang, X., Yanagisawa, H., Takasaka, N., Nishimura, S. L., Calfee, C. S., & Matthay, M. A. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx062 · Cited by 34
Moazed, F., Hendrickson, C., Jauregui, A., Gotts, J., Conroy, A., Delucchi, K., Zhuo, H., Arambulo, M., Vessel, K., Ke, S., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1098oc · Cited by 37
Bonneau, S., Landry, C., Bégin, S., Adam, D., Villeneuve, L. R., Clavet‐Lanthier, M., Dasilva, A., Charles, E., Dumont, B. L., Neagoe, P., et al. (2022) · Cells · doi:10.3390/cells11213420 · Cited by 32
“In humans, priming and activation of circulating neutrophils is likely to occur, given the highly proinflammatory environment in donors and recipients [4,5,9,19,20].”
BackgroundJin, Z., Suen, K. C., Wang, Z., & Ma, D. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02823-6 · Cited by 33
Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial
Ghadimi, K., Cappiello, J. L., Cooter-Wright, M., Haney, J. C., Reynolds, J. M., Bottiger, B., Klapper, J. A., Levy, J. H., Hartwig, M. G., INSPIRE-FLO Investigators, et al. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.5856 · Cited by 33
Self-citationPredictors of nonuse of donation after circulatory death lung allografts
Choi, A. Y., Jawitz, O. K., Raman, V., Mulvihill, M. S., Halpern, S. E., Barac, Y. D., Klapper, J. A., & Hartwig, M. G. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.04.111 · Cited by 31
Halpern, S. E., Au, S., Kesseli, S. J., Krischak, M. K., Olaso, D., Bottiger, B., Haney, J. C., Klapper, J. A., & Hartwig, M. G. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.05.008 · Cited by 32
The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction
McGinniss, J. E., Whiteside, S. A., Deek, R. A., Simón‐Soro, Á., Graham-Wooten, J., Oyster, M. L., Brown, M., Cantu, E., Diamond, J. M., Li, H., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2786oc · Cited by 31
Self-citationLeft Ventricular Dysfunction After Lung Transplantation for Pulmonary Arterial Hypertension
Gupta, S., Torres, F., Bollineni, S., Mohanka, M. R., & Kaza, V. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.07.040 · Cited by 31
Nykänen, A. I., Keshavjee, S. H., & Liu, M. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.01.016 · Cited by 32
Tague, L. K., Bedair, B., Witt, C. A., Byers, D. E., Guillamet, R. V., Kulkarni, H. S., Alexander‐Brett, J. M., Nava, R. G., Puri, V., Kreisel, D., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.06.016 · Cited by 31
Wu, S., Zhao, L., Ye, M., Liu, C., Liu, H., He, X., Qin, Y., Liang, F., Pan, L., & Lin, F. (2021) · BioMed Research International · doi:10.1155/2021/4525988 · Cited by 32
“LIRI is therefore a major complication after lung transplantation and pulmonary embolism [2, 3] and causes organ dysfunction and worse outcomes in patients [4, 5].”
BackgroundThe Evolution of Anesthesia for Lung Transplantation
Sellers, D., Demajo, W., Keshavjee, S. H., & Slinger, P. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.11.034 · Cited by 30
Argon and xenon ventilation during prolonged ex vivo lung perfusion
Martens, A., Montoli, M., Faggi, G., Katz, I. M., Pype, J. L., Vanaudenaerde, B. M., Raemdonck, D. E. V., & Neyrinck, A. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.10.007 · Cited by 29
“[5] Diamond JM, Lee JC, Kawut SM, et al.”
BackgroundExtracorporeal membrane oxygenation post lung transplantation
Castleberry, A. W., Hartwig, M. G., & Whitson, B. A. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328365197e · Cited by 33
“Therefore, the authors favor initiating ECMO support when ventilatory requirements reach a peak inspiratory pressure of 35 cmH2O or FiO2 surpasses 60% in order to reduce oxidative stress and lung injury from aggressive mechanical ventilation [6,27].”
BackgroundChakos, A., Ferret, P., Muston, B. T., Yan, T. D., & Tian, D. H. (2020) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2020.01.02 · Cited by 30
“PGD3 at 72 hours has been found to correlate with increased 30-day, 90-day, and 1-year mortality (26,28), as well as chronic lung allograft dysfunction (27).”
BackgroundEarly postoperative complications in lung transplant recipients
Soetanto, V., Grewal, U. S., Mehta, A. C., Shah, P., Varma, M. R., Garg, D., Majumdar, T., Dangayach, N. S., & Grewal, H. S. (2021) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-021-01178-1 · Cited by 30
Self-citationTao, J., Sorokina, E. M., Vázquez‐Medina, J. P., Mishra, M. K., Yamada, Y., Satalin, J. M., Nieman, G. F., Nellen, J. R., Beduhn, B., Cantu, E., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13794 · Cited by 29
Self-citationPrimary Graft Dysfunction after Lung Transplantation
Altun, G. T., Arslantaş, M. K., & Cinel, İ. (2020) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2015.16443 · Cited by 32
Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice
Gotts, J. E., Chun, L. F., Abbott, J. A., Fang, X., Takasaka, N., Nishimura, S. L., Springer, M. L., Schick, S. F., Calfee, C. S., & Matthay, M. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00405.2017 · Cited by 29
Sequence of refusals for donor quality, organ utilization, and survival after lung transplantation
Singh, E., Schecter, M. G., Towe, C. T., Rizwan, R., Bryant, R., Tweddell, J. S., Hossain, M. M., Morales, D. L. S., & Zafar, F. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.08.009 · Cited by 29
“Similar results have been shown in previous studies [13,14-17].”
ResultCalabrese, D. R., Tsao, T., Magnen, M., Valet, C., Gao, Y., Mallavia, B., Tian, J. J., Aminian, E., Wang, K. M., Shemesh, A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164603 · Cited by 28
“These were adopted from findings in the multicenter Lung Transplant Outcomes Group(2) and consistent with contemporary recommendations for the selection of covariates based on plausible biologic rationale (2, 65).”
InfluentialSelf-citationSun, Z., You, T., Zhang, B., Liu, Y., & Liu, J. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12688 · Cited by 28
Julliard, W. A., Meyer, K. C., Oliveira, N. C. D., Osaki, S., Cornwell, R. D., Sonetti, D. A., & Maloney, J. D. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207354 · Cited by 28
Complications of Lung Transplantation
Tejwani, V., Panchabhai, T. S., Kotloff, R. M., & Mehta, A. C. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.019 · Cited by 29
Massive donor transfusion potentially increases recipient mortality after lung transplantation
Borders, C. F., Suzuki, Y., Lasky, J., Schaufler, C., Mallem, D., Lee, J. D., Carney, K. C., Bellamy, S. L., Bermudez, C. A., Localio, A. R., et al. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.12.006 · Cited by 28
Self-citationPerioperative circulatory support for lung transplantation
Ohsumi, A., & Date, H. (2021) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-021-01610-8 · Cited by 27
“In addition, the 90-day mortality rate was 3.2% and the 2-year survival rate was 86%, with the lowest reported PGD rates at that time [16].”
BackgroundInfluentialPostoperative management of lung transplant recipients
Kao, C. C., & Parulekar, A. D. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.05.60 · Cited by 33
Developing machine learning models to predict primary graft dysfunction after lung transplantation
Michelson, A. P., Oh, I. Y., Gupta, A., Puri, V., Kreisel, D., Gelman, A. E., Nava, R. G., Witt, C. A., Byers, D. E., Halverson, L. P., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.07.008 · Cited by 27
The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation
Diamond, J. M., Cantu, E., Calfee, C. S., Anderson, M. R., Clausen, E. S., Shashaty, M. G. S., Courtwright, A., Kalman, L., Oyster, M. L., Crespo, M. M., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202303-0358oc · Cited by 30
Self-citationUpdate in Chronic Lung Allograft Dysfunction
Shah, R., & Diamond, J. M. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.07.009 · Cited by 28
Self-citationTakahashi, T., Terada, Y., Pasque, M. K., Nava, R. G., Kozower, B. D., Meyers, B. F., Patterson, G. A., Kreisel, D., Puri, V., & Hachem, R. R. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.12.038 · Cited by 28
Cantu, E., Suzuki, Y., Diamond, J. M., Ellis, J., Tiwari, J. L., Beduhn, B., Nellen, J. R., Shah, R., Meyer, N. J., Lederer, D. J., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13525 · Cited by 26
“blinded readers and adjudication as previously described (2).”
BackgroundMethodResultInfluentialSelf-citationEx vivo administration of trimetazidine improves post-transplant lung function in pig model†
Coşgun, T., İskender, İ., Yamada, Y., Arni, S., Lipiski, M., van Tilburg, K., Weder, W., & İnci, İ. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx053 · Cited by 26
Shashaty, M. G. S., Forker, C. M., Miano, T. A., Wu, Q., Yang, W. P., Oyster, M. L., Porteous, M. K., Cantu, E., Diamond, J. M., & Christie, J. D. (2019) · Clinical Transplantation · doi:10.1111/ctr.13678 · Cited by 27
Self-citationIntraoperative Support for Primary Bilateral Lung Transplantation: A Propensity-Matched Analysis
Chan, E. G., Hyzny, E. J., Furukawa, M., Ryan, J. P., Subramaniam, K., Morrell, M. R., Pilewski, J. M., Luketich, J. D., & Sánchez, P. G. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.06.014 · Cited by 26
Bèchet, N. B., Celik, A., Mittendorfer, M., Wang, Q., Huzevka, T., Kjellberg, G., Bodén, E., Hirdman, G., Pierre, L., Niroomand, A., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.10.033 · Cited by 28
Update in Lung Transplantation 2013
Todd, J. L., Christie, J. D., & Palmer, S. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0384up · Cited by 25
Self-citationVolatile organic compound profiling to explore primary graft dysfunction after lung transplantation
Stefanuto, P., Romano, R., Rees, C. A., Nasir, M., Thakuria, L., Simon, A. R., Reed, A. K., Marczin, N., & Hill, J. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-05994-2 · Cited by 25
“…clinical determinants of PGD, however, no obvious donor or recipient characteristic was associated with the development of PGD. Intraoperative factors such as cardiopulmonary bypass and invasiveness of surgery were investigated, as these aspects have been suggested as potential risk factors 5,36 .”
BackgroundMethodResultXu, Z., Sharma, M., Gelman, A. E., Hachem, R. R., & Mohanakumar, T. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.08.028 · Cited by 24
A new lung donor score to predict short and long-term survival in lung transplantation
Ehrsam, J. P., Held, U., Opitz, I., & İnci, İ. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-2043 · Cited by 25
“%) experienced PGD3.”
BackgroundInfluentialPrimary graft dysfunction following lung transplantation: From pathogenesis to future frontiers
Singh, S., De, S. D., Al‐Adhami, A., Singh, R., Hopkins, P. M.-A., & Curry, P. (2023) · World Journal of Transplantation · doi:10.5500/wjt.v13.i3.58 · Cited by 27
Peláez, A., Mitchell, P. O., Shah, N. S., Force, S. D., Elon, L., Brown, L. A. S., & Guidot, D. M. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000361 · Cited by 24
Lung Transplantation in Patients With Systemic Sclerosis
Shah, R., & Boin, F. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0650-z · Cited by 24
Self-citationRaphael, J., Collins, S. R., Wang, X.-Q., Scalzo, D. C., Singla, P., Lau, C. L., Kozower, B. D., Durieux, M. E., & Blank, R. S. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.05.007 · Cited by 24
Outcome of Lung Transplantation Using Grafts From Donors Over 65 Years of Age
Renard, R., Girault, A., Avramenko-Bouvier, A., Roussel, A., Cerceau, P., Pellenc, Q., Bunel, V., Godet, C., Jébrak, G., Messika, J., et al. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.10.018 · Cited by 24
The impact of waiting list BMI changes on the short-term outcomes of lung transplantation
Jomphe, V., Mailhot, G., Damphousse, V., Tahir, M.-R., Receveur, O., Poirier, C., & Ferraro, P. (2018) · Transplantation · doi:10.1097/tp.0000000000001919 · Cited by 23
“8) Age at transplant: median (IQR), y 30 (23-49) 52 (38-59) 55 (51-61) Underlying diseases, n (%)”
Calabrese, D. R., Ekstrand, C. A., Yellamilli, S., Singer, J. P., Hays, S. R., Leard, L. E., Shah, R., Venado, A. E., Kolaitis, N. A., Perez, A. A., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.02.007 · Cited by 26
Self-citationPrimary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
Roesel, M. J., Sharma, N., Schroeter, A., Matsunaga, T., Xiao, Y., Zhou, H., & Tullius, S. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891564 · Cited by 25
Kolaitis, N. A., Chen, H., Calabrese, D. R., Kumar, K., Obata, J., Bach, C., Golden, J. A., Simon, M. A. M., Kukreja, J., Hays, S. R., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0217oc · Cited by 23
Atchade, E., Boughaba, A., Tran‐Dinh, A., Jean‐Baptiste, S., Tanaka, S., Copelovici, L., Lortat‐Jacob, B., Roussel, A., Castier, Y., Messika, J., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160621 · Cited by 30
“High blood pressure, n (%) 56 (25) 17(27) 39 (24) 0.”
BackgroundTaghavi, S., Jayarajan, S. N., Komaroff, E., Horai, T., Brann, S. H., Patel, N., CORDOVA, F. C., Criner, G. J., Guy, T. S., & Toyoda, Y. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.05.018 · Cited by 23
Impact of Delayed Chest Closure on Surgical Site Infection After Lung Transplantation
Aguilar, P. R., Bemiss, B., Witt, C. A., Byers, D. E., Kreisel, D., Puri, V., Meyers, B. F., Patterson, G. A., Krupnick, A. S., Yusen, R. D., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.05.023 · Cited by 23
“Although considerable progress has been made in understanding the pathogenesis of PGD and clinical risk factors have been identified [5], treatment has been limited to supportive care and minimizing additional lung injury.”
BackgroundCirculatory support during lung transplantation
Kiziltug, H., & Falter, F. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000806 · Cited by 25
“All rights rese lung transplantation has been identified as an independent risk factor for reperfusion injury, early graft dysfunction and severe PGD [13] potentially because of the activation of inflammatory mediators, increased pulmonary oedema and longer operative times [19].”
BackgroundInfluentialAnalysis of Outcomes in Lung Transplantation
Martin, A. K., Renew, J. R., Jayaraman, A. L., Murray, A. W., Fritz, A. V., & Ramakrishna, H. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.06.014 · Cited by 23
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.